查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1864366

电穿孔设备市场按产品类型、应用、最终用户、技术类型和细胞类型划分－2025-2032年全球预测

Electroporation Instrument Market by Product Type, Application, End User, Technology Type, Cell Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，电穿孔设备市场将成长至 4.3772 亿美元，复合年增长率为 5.69%。

主要市场统计数据
基准年 2024 2.81亿美元
预计年份：2025年 2.9689亿美元
预测年份：2032年 4.3772亿美元
复合年增长率 (%) 5.69%

现代电穿孔设备简述：重点关注技术作用、操作重点以及科学研究和临床使用者不断变化的需求

电穿孔装置是现代生命科学的核心工具，能够控制细胞膜的通透性，进而促进核酸、蛋白质和小分子的导入。这一系列技术涵盖了核心研究实验室使用的桌上型系统，以及新兴的携带式设备，这些设备拓展了其在现场和即时医疗中的应用。过去十年，仪器外形尺寸和耗材设计的不断改进，使得通量、可重复性和与上下游工作流程的整合成为优先考虑的因素。因此，采购部门和实验室管理人员越来越关注营运价值，而不仅仅是资本投资成本。

微流体自动化和治疗主导的需求如何重塑研究和临床工作流程中的电穿孔工具整合、耗材和数据策略

由于技术融合、监管日趋成熟以及终端用户需求的变化，电穿孔技术领域正经历快速变革。微流体和连续流电穿孔技术的进步提高了通量和一致性，从而改变了实验室的设计方式以及製造商的产品蓝图。同时，基因编辑和细胞疗法的兴起推动了对兼具製程控制和可追溯耗材的系统的需求，促使供应商加大对平台标准化和整合能力的投资。这些变化并非孤立发生，而是与实验室自动化、数位化和以数据为中心的品质保证等更广泛的趋势紧密相连。

评估2025年关税主导的供应链调整如何重塑电穿孔生态系中的采购成本结构、组件供应和采购优先事项。

2025年推出的关税和贸易措施对电穿孔供应链产生了显着的连锁反应，促使製造商和实验室采购负责人重新评估筹资策略和成本结构。精密电极、专用比色皿和脉衝控制电子组件等经常交叉运输的组件，其到岸成本和前置作业时间波动性均增加。这导致原始设备製造商 (OEM) 加快供应商多元化、区域製造投资和双重采购策略，以保护关键生产线。对于学术机构、受託研究机构和商业机构的采购团队而言，新的贸易环境更加凸显了供应可视性和合约应急计画的重要性。

全面的市场区隔分析揭示了产品类型、应用、终端用户技术和细胞分类如何影响购买行为和研发重点。

电穿孔设备市场结构在多个维度上呈现高度分层：产品、应用、终端用户、技术和细胞类型，每个维度都会影响购买决策和产品开发优先顺序。就产品类型而言，市场分为配件/耗材和设备两大类。配件/耗材包括比色皿、电极和流动池等关键零件，这些零件决定了实验的可重复性和单次实验成本。同时，设备平台分为桌上型和携带式，桌上型设备根据通量和通讯协定的复杂程度进一步细分为多脉衝系统和单脉衝系统。

美洲、欧洲、中东和非洲以及亚太地区的区域采用模式、监管差异和供应链波动都会影响采购和部署。

区域趋势对实施模式、监管预期和供应链架构有显着影响。在美洲，对先进治疗方法和转化研究的投资推动了对高性能台式系统和检验耗材的强劲需求，而大规模生物製药公司和合约研究网络的存在则促进了伙伴关係的建立和早期技术的应用。这种环境加速了支援临床级处理并与现有实验室自动化生态系统良好整合的平台的普及。随着我们从北美转向南美，采购预算和基础设施成熟度的差异将影响实施策略和售后服务模式。

分析决定电穿孔产业领导地位和细分市场机会的竞争定位、创新、伙伴关係和服务模式

电穿孔生态系的竞争格局由现有设备製造商、专业耗材供应商以及专注于连续流技术和微型化设备的新兴技术参与企业共同构成。现有企业通常凭藉其广泛的平台功能、成熟的通讯协定和全球服务网络展开竞争，而新兴新兴企业则透过创新的脉衝演算法、微流体技术和软体驱动的製程控制来脱颖而出。设备原始设备製造商 (OEM) 与耗材专家之间的合作日益普遍，从而能够提供垂直整合的解决方案，降低采购的不确定性并简化客户的采购流程。

为製造商和买家提供切实可行的策略倡议，以增强供应链韧性、加速差异化，并在电穿孔解决方案中融入持续价值。

产业领导者应优先考虑增强供应链韧性、加速产品差异化并提升客户终身价值。首先，应实现零件和耗材采购多元化，同时建立区域製造地和分销中心，以降低关税和物流风险。这既能确保生产的连续性，又能减少因前置作业时间而导致的专案风险。其次，应投资连续流和微流体技术，作为桌上型产品的策略拓展。这些技术能够满足商业开发商和高效能研究客户对吞吐量和一致性的关键需求。第三，应将数位化过程监控和检验的通讯协定纳入产品系列，以记录符合临床和监管要求的可重复性和可追溯性。

我们采用透明、多方面的研究途径，结合专家访谈、文献综述、专利分析和情境检验，为我们的实务发现和建议提供了支持。

本分析整合了定性和定量研究，采用多阶段调查方法，旨在获得全面的行业洞察和检验。主要研究包括对各领域专家的深入访谈，涵盖仪器工程、耗材製造、学术和临床机构的采购人员，以及製药和生物技术公司的高级研发经理。这些访谈为产品、应用和最终用户需求的主题映射提供了信息，并提供了有关运营限制（例如法规遵从性和供应链依赖性）的背景信息。

一份简明扼要、全面全面的分析报告，重点阐述了技术演进、供应链韧性和商业策略的融合如何决定电穿孔市场近期的成功。

电穿孔设备及相关耗材处于科学研究创新与治疗开发的关键交会点。无论产品类型、应用领域或地理为何，能够展现可重复效能、应对力法规要求且供应可靠的供应商都具有优势。从连续流系统到整合资料平台的技术转型正在改变人们的预期，并开闢新的商业化路径。同时，贸易措施和不断演变的筹资策略等外部因素正在加速向更具韧性、以服务为导向的经营模式转型。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 脉衝电场消融电穿孔系统在治疗心律不整的应用
  • 开发携带式奈米孔电穿孔装置，用于现场快速检测病原体。
  • 利用射频双极脉衝电穿孔提高大分子质体DNA的转染效率
  • 透过整合机器学习演算法实现即时电穿孔参数优化和品管
  • 推出一种一次性微流体比色皿，旨在最大程度地减少电穿孔实验中的交叉污染。
  • 利用电穿孔技术扩展植物基因组编辑平台，以培育耐旱作物
  • 引入基于云端的软体平台，用于远端监控和控制电穿孔通讯协定
  • 设备製造商与学术机构进行策略合作，以规范电穿孔工作流程

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：依产品类型分類的电穿孔设备市场

  • 配件和耗材
    • 比色皿
    • 电极
    • 流动池
  • 装置
    • 桌面型
      • 多重脉衝
      • 单脉衝
    • 手持式

第九章 按应用分類的电穿孔设备市场

  • 学术研究
    • 癌症研究
    • 分子生物学
    • 疫苗研发
  • CRO（受託研究机构）
    • 临床研究
    • 临床前研究
  • 药物生物技术
    • 农业生物技术
    • 细胞疗法
    • 基因治疗

第十章 按最终用户分類的电穿孔设备市场

  • 学术和研究机构
  • CRO（受託研究机构）
  • 医院诊所
  • 製药和生物技术公司

第十一章 依技术类型分類的电穿孔设备市场

  • 批次类型
  • 连续流

第十二章：按细胞类型分類的电穿孔设备市场

  • 贴壁细胞
    • 昆虫细胞
    • 哺乳动物贴壁细胞
    • 植物细胞
  • 悬浮细胞
    • 细菌悬浮细胞
    • 哺乳动物悬浮细胞
    • 酵母菌细胞

第十三章 电穿孔设备市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 电穿孔设备市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国电穿孔设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Thermo Fisher Scientific Inc.
    • Lonza Group AG
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
    • Eppendorf AG
    • Harvard Bioscience, Inc.
    • MaxCyte, Inc.
    • BEX Co., Ltd.
    • Nepa Gene Co., Ltd.
    • CytoPulse Sciences, Inc.
Product Code: MRR-E1122A48A8B0

The Electroporation Instrument Market is projected to grow by USD 437.72 million at a CAGR of 5.69% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 281.00 million
Estimated Year [2025] USD 296.89 million
Forecast Year [2032] USD 437.72 million
CAGR (%) 5.69%

A concise orientation to contemporary electroporation instruments highlighting technological roles operational priorities and the evolving expectations of research and clinical users

Electroporation instruments are central tools in contemporary life sciences, enabling the controlled permeabilization of cellular membranes to facilitate the delivery of nucleic acids, proteins, and small molecules. This suite of technologies spans bench-top systems used in core research laboratories to emerging handheld devices that expand in-field and point-of-care applications. Over the past decade, the evolution of instrument form factors and consumable design has shifted priorities toward throughput, reproducibility, and integration with upstream and downstream workflows. Consequently, procurement teams and laboratory directors increasingly emphasize total operational value rather than capital cost alone.

Moreover, electroporation has moved beyond a niche laboratory technique to a foundational enabler for advanced therapies and complex molecular biology workflows. Clinical-grade delivery for cell and gene therapies demands rigorous process control, traceable consumables, and validated protocols, while academic and translational research groups prioritize flexibility and rapid prototyping. As a result, manufacturers are balancing the need for regulatory-compliant platforms with modular architectures that support diverse research applications. Transitioning from basic technique to platform-level thinking, stakeholders must now weigh instrument interoperability, consumable lifecycle management, and services that reduce time-to-data for high-stakes programs.

How microfluidics automation and therapy-driven requirements are reshaping electroporation tools integration consumables and data strategies across research and clinical workflows

The electroporation landscape is undergoing rapid transformation driven by technological convergence, regulatory maturation, and changing end-user expectations. Advances in microfluidics and continuous-flow electroporation technologies are enabling higher throughput and greater consistency, which, in turn, are reshaping how laboratories design experiments and how manufacturers structure product roadmaps. At the same time, the rise of gene editing and cell therapies has increased demand for systems that combine process control with traceable consumables, prompting suppliers to invest in platform-standardization and integration capabilities. These shifts are not occurring in isolation; rather, they are linked to broader trends in laboratory automation, digitalization, and data-centric quality assurance.

In parallel, miniaturization and portability have expanded use-cases for handheld and benchtop instruments, enabling decentralized workflows and point-of-care research settings. Integration with laboratory information management systems and data analytics tools is becoming a differentiator, as customers seek reproducible protocols and real-time process monitoring. Notably, consumables design is also evolving: disposability for contamination control, precision-engineered cuvettes and electrodes for reduced variability, and flow cell geometries optimized for specific cell types are becoming market requirements. As a result, competitive advantage increasingly depends on the ability to offer holistic solutions that combine hardware, consumables, software, and service.

Assessing the 2025 tariff-driven supply chain adjustments that have reshaped sourcing cost structures component availability and procurement priorities in electroporation ecosystems

The introduction of tariffs and trade measures in 2025 has created material ripple effects across the electroporation supply chain, prompting manufacturers and laboratory buyers to reassess sourcing strategies and cost structures. Components that are frequently cross-shipped-such as precision electrodes, specialized cuvettes, and electronic assemblies for pulse control-have experienced increased landed costs and lead-time volatility. Consequently, original equipment manufacturers have accelerated supplier diversification, regional manufacturing investments, and dual-sourcing strategies to protect critical production lines. For procurement teams in academic, contract research, and commercial settings, the new trade environment has reinforced the importance of supply visibility and contract contingencies.

Furthermore, tariffs have magnified the relative cost impact of consumables in high-frequency usage contexts, incentivizing laboratories to evaluate consumable efficiency and compatibility across platforms. In response, several suppliers have emphasized local stocking agreements and expanded aftermarket services to reduce the operational risks associated with cross-border delays. For multinational purchasers, tariff-induced pricing pressure has prompted negotiations around bundled service contracts, extended warranties, and volume-based commitments. Ultimately, the cumulative effect is a shift toward supply chain resilience and service-oriented commercial models, which moderate the immediate price shock while aligning supplier incentives with customer continuity and regulatory compliance.

Comprehensive segmentation review clarifying how product types applications end users technologies and cell classifications drive purchasing behavior and R&D priorities

The market architecture for electroporation instruments is richly stratified across product, application, end-user, technology, and cell-type dimensions, each of which informs purchasing decisions and product development priorities. From the perspective of product type, the landscape is split between accessories and consumables and instruments. Accessories and consumables include requisite items such as cuvettes, electrodes, and flow cells that determine repeatability and per-experiment economics, while instrument platforms differentiate into bench-top and handheld solutions, with bench-top devices further subdivided into multi-pulse and single-pulse systems that align with throughput and protocol complexity.

Application-focused segmentation highlights distinct workflow requirements: academic research encompasses domains like cancer research, molecular biology, and vaccine development where flexibility and method development are key; contract research organizations operate across clinical and preclinical research and therefore prioritize validated processes, scalability, and documentation; pharmaceutical and biotechnology users address areas such as agricultural biotechnology, cell therapy, and gene therapy where regulatory rigor and process transferability dominate procurement decisions. End-user categories reflect the purchasing contexts of academic and research institutions, contract research organizations, hospitals and clinics, and pharmaceutical and biotechnology companies, each presenting unique service expectations and compliance profiles.

Technology-type considerations bifurcate into batch and continuous flow approaches, with continuous flow gaining traction where homogeneity and high throughput are essential. Cell-type segmentation further refines instrument and consumable requirements: adherent cells, including insect, mammalian adherent, and plant cells, impose constraints on handling and electroporation parameters, while suspension cells-comprising bacterial suspension, mammalian suspension, and yeast cells-demand alternate delivery geometries and flow dynamics. Collectively, these segmentation layers influence product roadmaps, go-to-market tactics, and aftersales offerings, and they underscore the need for manufacturers to align platform capabilities with the nuanced demands of each customer cohort.

Regional adoption patterns regulatory nuances and supply chain variations across the Americas Europe Middle East Africa and Asia-Pacific that influence procurement and deployment

Regional dynamics exert a pronounced influence on adoption patterns, regulatory expectations, and supply chain architecture. In the Americas, investment in advanced therapies and translational research has driven strong demand for high-capability bench-top systems and validated consumables, while the presence of large biopharma and contract research networks fosters partnerships and early technology adoption. This environment accelerates the uptake of platforms that support clinical-grade processing and integrates well with established laboratory automation ecosystems. Moving from North to South within the region, variations in procurement budgets and infrastructure maturity shape deployment strategies and aftermarket service models.

Across Europe, Middle East & Africa, stakeholders contend with a diverse regulatory environment and a mix of established research institutions and emerging biotech clusters. European centers of excellence emphasize reproducibility, regulatory compliance, and interoperability with certified laboratory equipment, prompting suppliers to prioritize robust documentation and localized technical support. In parts of the Middle East and Africa, pioneering investments in life sciences and agricultural biotech are creating nascent markets for portable and cost-efficient instruments, while regional partnerships often focus on knowledge transfer and capacity building.

The Asia-Pacific region displays rapid commercial expansion driven by growing biotechnology sectors, high-throughput manufacturing facilities, and a large base of research institutions. Local manufacturing capabilities and government-backed innovation programs have encouraged the development of domestic suppliers and hybrid sourcing strategies. Meanwhile, end users across the region show a strong appetite for continuous-flow solutions and scalable platforms that can serve both research and commercial production workflows. Taken together, these regional dynamics call for nuanced market entry strategies, differentiated service footprints, and localized product adaptations.

An analysis of competitive positioning innovation partnerships and service models that determine leadership and niche opportunity capture within the electroporation industry

Competitive dynamics in the electroporation ecosystem are shaped by a combination of legacy instrument manufacturers, specialized consumable providers, and emerging technology entrants focused on continuous flow and miniaturized devices. Established players typically compete on the breadth of platform capabilities, proven protocols, and global service networks, while newer companies differentiate through novel pulse algorithms, microfluidic innovations, and software-enabled process control. Alliances between instrument OEMs and consumable specialists have become increasingly common, enabling vertically integrated solutions that reduce variability and simplify customer procurement.

Strategic activity has also concentrated on after-sales services, consumable capture models, and partnerships with clinical and academic centers to validate new applications. Companies that secure preferred supplier status within large research networks benefit from recurring consumable revenue streams and early access to protocol adaptations. Patent portfolios around pulse-shaping technologies, electrode materials, and flow-cell architectures contribute to competitive moats, and firms with modular platforms can accelerate adoption by offering upgrade paths rather than full replacements. Looking ahead, organizations that combine rigorous regulatory support with flexible commercial options and strong technical service capabilities will maintain leadership positions while new entrants seize niche opportunities through focused innovation.

Practical strategic initiatives for manufacturers and purchasers to strengthen supply resilience accelerate differentiation and embed recurring value across electroporation solutions

Industry leaders should prioritize strategies that reinforce supply resilience, accelerate product differentiation, and enhance customer lifetime value. First, diversify component and consumable sourcing while establishing regional manufacturing or distribution hubs to mitigate tariff and logistics exposure; this will preserve production continuity and reduce lead-time-driven program risk. Second, invest in continuous-flow and microfluidic capabilities as strategic extensions of bench-top offerings, because these technologies address throughput and consistency requirements that matter to both commercial developers and high-throughput research customers. Third, embed digital process monitoring and validated protocols into product portfolios to deliver reproducibility and traceability that align with clinical and regulatory expectations.

In addition, cultivate deeper partnerships with contract research organizations, hospitals, and large academic centers to co-develop workflows and secure early validation of new consumables and pulse regimes. Consider bundled commercial models that combine hardware, consumables, software, and service to provide predictable total cost of ownership and to lock in recurring revenue. Finally, prioritize a modular platform strategy that enables incremental upgrades and aftermarket monetization, while investing in customer education and technical support programs that reduce barriers to adoption and accelerate technology transfer from the laboratory to clinical or commercial environments.

A transparent multi-method research approach integrating expert interviews literature review patent analysis and scenario validation to underpin actionable insights and recommendations

This analysis synthesizes qualitative and quantitative research conducted through a multi-step methodology designed to achieve comprehensive sector insight and validation. Primary research included in-depth interviews with subject-matter experts spanning instrument engineering, consumables manufacturing, procurement leads within academic and clinical institutions, and senior R&D managers in pharmaceutical and biotechnology firms. These interviews informed thematic mapping of product, application, and end-user requirements, and they provided context for operational constraints such as regulatory compliance and supply chain dependencies.

Secondary research comprised an exhaustive review of technical literature, regulatory guidance, patent filings, company disclosures, and trade publications to triangulate technological trends and competitive activity. Data were further validated through cross-referencing of procurement procedures, public tender records, and reported collaboration announcements to ensure that observed trends reflected operational realities. Analytical techniques included segmentation mapping, scenario analysis for supply chain disruptions, and qualitative benchmarking of service propositions. Finally, findings were peer-reviewed by an internal expert panel and refined to ensure that conclusions are actionable for decision-makers in procurement, R&D, and corporate strategy roles.

A concise synthesis highlighting the convergence of technological evolution supply resilience and commercial strategies that will determine near-term success in electroporation markets

Electroporation instruments and their associated consumables now occupy a strategic intersection between research innovation and therapeutic development. Across product types, applications, and regions, the landscape favors suppliers that can demonstrate reproducible performance, regulatory readiness, and supply reliability. Transformations in technology-from continuous-flow systems to integrated data platforms-are altering expectations and creating new pathways for commercialization. At the same time, external forces such as trade measures and evolving procurement strategies are accelerating the shift toward resilient, service-oriented business models.

For stakeholders, the imperative is clear: align platform development with real-world workflow needs, invest in consumable standardization and validation, and pursue commercial models that prioritize long-term partnerships over transactional sales. By doing so, organizations can reduce operational friction, support faster translational timelines, and capture value across the instrument lifecycle. In sum, the immediate window of opportunity favors those who combine technical excellence with pragmatic supply and commercial strategies to support the next generation of research and therapeutic programs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of pulsed field ablation electroporation systems in cardiac arrhythmia therapy
  • 5.2. Development of handheld nanopore-enabled electroporation devices for rapid on-site pathogen detection
  • 5.3. Use of high-frequency bipolar pulse electroporation to enhance large plasmid DNA transfection efficiency
  • 5.4. Integration of machine learning algorithms for real-time electroporation parameter optimization and quality control
  • 5.5. Emergence of disposable microfluidic cuvettes designed to minimize cross-contamination in electroporation assays
  • 5.6. Expansion of electroporation-based plant genome editing platforms for drought-resistant crop development
  • 5.7. Implementation of cloud-connected software platforms for remote monitoring and controlling electroporation protocols
  • 5.8. Strategic partnerships between device manufacturers and academic institutions to standardize electroporation workflows

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Electroporation Instrument Market, by Product Type

  • 8.1. Accessories & Consumables
    • 8.1.1. Cuvettes
    • 8.1.2. Electrodes
    • 8.1.3. Flow Cells
  • 8.2. Instruments
    • 8.2.1. Bench-Top
      • 8.2.1.1. Multi Pulse
      • 8.2.1.2. Single Pulse
    • 8.2.2. Handheld

9. Electroporation Instrument Market, by Application

  • 9.1. Academic Research
    • 9.1.1. Cancer Research
    • 9.1.2. Molecular Biology
    • 9.1.3. Vaccine Development
  • 9.2. Contract Research Organizations
    • 9.2.1. Clinical Research
    • 9.2.2. Preclinical Research
  • 9.3. Pharmaceutical & Biotechnology
    • 9.3.1. Agricultural Biotechnology
    • 9.3.2. Cell Therapy
    • 9.3.3. Gene Therapy

10. Electroporation Instrument Market, by End User

  • 10.1. Academic & Research Institutions
  • 10.2. Contract Research Organizations
  • 10.3. Hospitals & Clinics
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Electroporation Instrument Market, by Technology Type

  • 11.1. Batch
  • 11.2. Continuous Flow

12. Electroporation Instrument Market, by Cell Type

  • 12.1. Adherent Cells
    • 12.1.1. Insect Cells
    • 12.1.2. Mammalian Adherent Cells
    • 12.1.3. Plant Cells
  • 12.2. Suspension Cells
    • 12.2.1. Bacterial Suspension Cells
    • 12.2.2. Mammalian Suspension Cells
    • 12.2.3. Yeast Cells

13. Electroporation Instrument Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Electroporation Instrument Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Electroporation Instrument Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific Inc.
    • 16.3.2. Lonza Group AG
    • 16.3.3. Bio-Rad Laboratories, Inc.
    • 16.3.4. Merck KGaA
    • 16.3.5. Eppendorf AG
    • 16.3.6. Harvard Bioscience, Inc.
    • 16.3.7. MaxCyte, Inc.
    • 16.3.8. BEX Co., Ltd.
    • 16.3.9. Nepa Gene Co., Ltd.
    • 16.3.10. CytoPulse Sciences, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ELECTROPORATION INSTRUMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ELECTROPORATION INSTRUMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ELECTROPORATION INSTRUMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CUVETTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CUVETTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CUVETTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CUVETTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CUVETTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CUVETTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ELECTRODES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ELECTRODES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ELECTRODES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ELECTRODES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ELECTRODES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ELECTRODES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY FLOW CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY FLOW CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY FLOW CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY FLOW CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY FLOW CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY FLOW CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MULTI PULSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MULTI PULSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MULTI PULSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MULTI PULSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MULTI PULSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MULTI PULSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SINGLE PULSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SINGLE PULSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SINGLE PULSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SINGLE PULSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SINGLE PULSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SINGLE PULSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HANDHELD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HANDHELD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HANDHELD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HANDHELD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HANDHELD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HANDHELD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CANCER RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CANCER RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CANCER RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CANCER RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MOLECULAR BIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MOLECULAR BIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MOLECULAR BIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MOLECULAR BIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MOLECULAR BIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MOLECULAR BIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY VACCINE DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY VACCINE DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY VACCINE DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY VACCINE DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CLINICAL RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CLINICAL RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CLINICAL RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CLINICAL RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY GENE THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY GENE THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTINUOUS FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTINUOUS FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTINUOUS FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTINUOUS FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSECT CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSECT CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSECT CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSECT CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSECT CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSECT CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN ADHERENT CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN ADHERENT CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN ADHERENT CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN ADHERENT CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN ADHERENT CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN ADHERENT CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PLANT CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PLANT CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PLANT CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PLANT CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PLANT CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PLANT CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BACTERIAL SUSPENSION CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BACTERIAL SUSPENSION CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BACTERIAL SUSPENSION CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BACTERIAL SUSPENSION CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BACTERIAL SUSPENSION CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BACTERIAL SUSPENSION CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN SUSPENSION CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN SUSPENSION CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN SUSPENSION CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN SUSPENSION CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN SUSPENSION CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN SUSPENSION CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY YEAST CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY YEAST CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY YEAST CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY YEAST CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY YEAST CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY YEAST CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA E